Last reviewed · How we verify

NCT04393129

Central Sensitization Symptoms and Psychosocial Factors in Athletes After ACL Reconstruction

Completed Last updated 19 May 2020
What this trial tests

trial in Anterior Cruciate Ligament Rupture in 39 participants. Completed in 5 March 2020.

Timeline
1 October 2019
Primary endpoint
27 February 2020
5 March 2020

Quick facts

Lead sponsorUniversity of Thessaly
StatusCompleted
Study typeOBSERVATIONAL
Enrollment39
Start date1 October 2019
Primary completion27 February 2020
Estimated completion5 March 2020
Sites1 location across Greece

Conditions studied

Sponsor

University of Thessaly

Who can join

Adults 18 to 45, any sex, with Anterior Cruciate Ligament Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main research objective of this study is whether athletes who have sustained an anterior cruciate ligament injury, experience chronic nociplastic pain and psychosocial factors, including kinesiophobia and pain catastrophizing, after having been through ACL reconstruction surgery and rehabilitation and have returned to sport.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Rupture

Currently open trials in the same condition.

Other University of Thessaly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04393129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing